Sputum Purulence as a Predictor of Cystic Fibrosis Exacerbations: a Prospective Cohort Trial.
NCT02309229 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2014-12-05
Summary
To use the sputum colour chart as a predictor for cystic fibrosis exaerbations
Conditions
Sponsors & Collaborators
-
Universitaire Ziekenhuizen KU Leuven
lead OTHER
Principal Investigators
-
Lieven J Dupont, MD, PhD · Universitaire Ziekenhuizen KU Leuven
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2013-12-31
- Completion
- 2014-01-31
Countries
- Belgium
Study Locations
More Related Trials
-
Evaluation of New Device for Beta-adrenergic Sweat Test in the Context of Stratification of Patient With Cystic Fibrosis
NCT06836453 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Salt Status in Patients With Cystic Fibrosis
NCT04556162 ·Status: COMPLETED
-
Early Intervention in Cystic Fibrosis Exacerbation
NCT01104402 ·Status: COMPLETED ·Phase: NA
-
Home Monitoring to Predict Exacerbation in Cystic Fibrosis
NCT02416375 ·Status: COMPLETED
-
Prognostic Value of Functional Exercise Test (EFX) in Cystic Fibrosis
NCT02994017 ·Status: COMPLETED ·Phase: NA
-
Molecular Diagnosis of Respiratory Viral Infections on Sputum From Cystic Fibrosis Patients
NCT03736096 ·Status: COMPLETED
-
Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis Patients
NCT00004296 ·Status: COMPLETED
-
Implementation of a Non-invasive Version of the Imaging β-adrenergic-dependent Sweat Secretion Test
NCT03584841 ·Status: UNKNOWN ·Phase: NA
-
Detection of Reductions in Cystic Fibrosis Airway Inflammation While Using Aztreonam Lysine Solution
NCT01736839 ·Status: COMPLETED
-
Cystic Fibrosis Foundation (CFF) Biomarkers of Exacerbation
NCT00788359 ·Status: COMPLETED
-
The Role of Bacteria and Genetic Variations in Cystic Fibrosis
NCT00043225 ·Status: COMPLETED
-
The Challenge of Obtaining Qualitative Bacterial Cultures in Non-expectorating Cystic Fibrosis Patients
NCT02363764 ·Status: COMPLETED
-
Utility of Induced Sputum Using Hypertonic Saline to Evaluate Infection and Inflammation in Cystic Fibrosis
NCT00721071 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Sensations of Breathlessness in Patients With Cystic Fibrosis
NCT01799642 ·Status: COMPLETED
-
Host and Bacterial Mechanisms During Cystic Fibrosis Pulmonary Exacerbations
NCT04354038 ·Status: COMPLETED
-
Evaluation of the Lung Clearance Index
NCT02342951 ·Status: COMPLETED ·Phase: NA
-
Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis
NCT00850551 ·Status: COMPLETED ·Phase: NA
-
Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
NCT06188988 ·Status: ENROLLING_BY_INVITATION
-
PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis
NCT02419989 ·Status: ENROLLING_BY_INVITATION
-
Sputum Validation for the Molecular Diagnosis of Respiratory Viral Infections in Cystic Fibrosis
NCT03684759 ·Status: COMPLETED
-
Bacterial Gene Profiling to Predict Antibiotic Resistance During Cystic Fibrosis Pulmonary Exacerbations
NCT04341532 ·Status: COMPLETED
-
Breath Condensate Study in Patients With Cystic Fibrosis.
NCT02056132 ·Status: COMPLETED
-
Self Drainage in Pediatric Cystic Fibrosis Patients
NCT01509235 ·Status: COMPLETED ·Phase: NA
-
Serum Zn Status of Patients With Cystic Fibrosis at Diagnosis and One Year Later, Compared to a Healthy Control Group
NCT00221559 ·Status: COMPLETED
-
A CFit Study - Baseline
NCT03234387 ·Status: TERMINATED